These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3148141)

  • 1. Ontogenetic transitions in the psychopharmacological response to serotonergic manipulations.
    Enters EK; Spear LP
    Psychopharmacology (Berl); 1988; 96(2):161-8. PubMed ID: 3148141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a "serotonergic syndrome" in neonatal rat pups?
    Ristine LA; Spear LP
    Pharmacol Biochem Behav; 1985 Feb; 22(2):265-9. PubMed ID: 2858868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of suckling in weaning-age rats: a possible serotonergic mechanism.
    Williams CL; Rosenblatt JS; Hall WG
    J Comp Physiol Psychol; 1979 Jun; 93(3):414-29. PubMed ID: 479391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological manipulation of milk-induced behaviors in three-day-old rat pups.
    Caza PA; Spear LP
    Pharmacol Biochem Behav; 1982 Mar; 16(3):481-6. PubMed ID: 6123119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quipazine-induced behavior in neonatal rat pups.
    Spear LP; Ristine LA
    Pharmacol Biochem Behav; 1981 Jun; 14(6):831-4. PubMed ID: 7255519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential behavioral responses in neonatal rat pups.
    Kirstein CL; Spear LP
    Eur J Pharmacol; 1988 Jun; 150(3):339-45. PubMed ID: 2970973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential behavioral responses in preweanling rat pups.
    Frambes NA; Kirstein CL; Moody CA; Spear LP
    Eur J Pharmacol; 1990 Jun; 182(1):9-17. PubMed ID: 2144825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suckling behavior of the infant rat: modulation by a developing neurotransmitter system.
    Nock B; Williams CL; Hall WG
    Pharmacol Biochem Behav; 1978 Mar; 8(3):277-80. PubMed ID: 206914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug and environmentally induced manipulations of the opiate and serotonergic systems alter nociception in neonatal rat pups.
    Spear LP; Enters EK; Aswad MA; Louzan M
    Behav Neural Biol; 1985 Jul; 44(1):1-22. PubMed ID: 3841749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of serotonergic agonists and antagonists on the locomotor activity of neonatal rats.
    Lucot JB; Seiden LS
    Pharmacol Biochem Behav; 1986 Mar; 24(3):537-41. PubMed ID: 3486425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serotonin agonist-antagonist reversible effect on Na+-K+-ATPase activity in the developing rat brain.
    Hernández RJ
    Dev Neurosci; 1982; 5(4):326-31. PubMed ID: 6291893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of quipazine and methysergide on play in juvenile rats.
    Normansell L; Panksepp J
    Pharmacol Biochem Behav; 1985 May; 22(5):885-7. PubMed ID: 2989950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor activity.
    Feigenbaum JJ; Yanai J; Klawans HL
    J Neural Transm; 1983; 57(1-2):27-37. PubMed ID: 6619829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of drugs influencing central serotonergic mechanisms on methamphetamine-induced stereotyped behavior in the rat.
    Balsara JJ; Jadhav JH; Muley MP; Chandorkar AG
    Psychopharmacology (Berl); 1979 Sep; 64(3):303-7. PubMed ID: 116272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced sensitivity to quipazine in the genetically dystonic rat (dt).
    Michela VL; Stratton SE; Lorden JF
    Pharmacol Biochem Behav; 1990 Sep; 37(1):129-33. PubMed ID: 2263655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic mechanisms in the nucleus accumbens affected by chronic desipramine treatment.
    Płaźnik A; Stefański R; Pałejko W; Kostowski W
    Pharmacol Biochem Behav; 1991 May; 39(1):43-8. PubMed ID: 1833782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACTH-induced behaviors and their modulation by serotonergic agonists differ in neonatal and weanling rat pups.
    Kirstein CL; Traber J; Gispen WH; Spear LP
    Psychopharmacology (Berl); 1990; 100(2):151-8. PubMed ID: 2154832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
    Langlais PJ; Gabay S
    J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered responses to serotonergic agents in Fawn-Hooded rats.
    Gudelsky GA; Koenig JI; Meltzer HY
    Pharmacol Biochem Behav; 1985 Mar; 22(3):489-92. PubMed ID: 3158004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.